Hattie Hayes

Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design

Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis

Dr Carl Regillo provided an overview of topline results – and a deep dive into subgroup analyses – of DAVIO 2 trial data

An in-depth case study conversation

Euan Thomson, Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit at Carl Zeiss Meditec, discusses plans for the company's vitreoretinal surgery workflows following announcement of DORC acquisition

The European Union approval applies to aflibercept 8 mg for treatment of nAMD and DME

A review of our most important content from throughout the year

Experts from around the globe converged in San Francisco, California

In early November, the EU MDR issued a CE mark certification for RetInSight’s AI-based geographic atrophy monitor

At this year's ESCRS meeting, industry leaders shared advice for young ophthalmologists–and what they wish they'd known earlier in their careers

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

Dr Marco Zarbin emphasises the importance of defining “active disease”

Mark Blecher, MD, spoke with the Ophthalmology Times team about his poster addressing retinal visualisation and patients who have undergone small aperture IOL implantation at this year's American Academy of Ophthalmology meeting

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Infrastructure across Europe needs a major overhaul to optimise education and patient access in groundbreaking treatments

The company received marketing authorisation approval in the EU earlier this year

The endorsement follows FDA approval in the United States this summer

At this year's American Academy of Ophthalmology meeting, Anthony Wallace, BS, MBA, vice president and general manager of the surgical business at Bausch + Lomb North America, spoke with us about three exciting new launches

The ESCRS Symposium focused on innovations in the digital cataract and refractive surgery space

The highlights from this year’s meeting, brought to you in conjunction with Modern Retina

Study results indicated low-light therapy can help prevent dry eye disease following cataract surgery

Dr Ali Erginay of Lariboisière Hospital in Paris, France, discusses his EURETINA presentation, "Introducing optomap® Ultra-widefield Colour Red-Green-Blue Multimodal Imaging"

Attendees share their favorite moments and memories from the 2023 ESCRS meeting

The new range of pure and premixed gases are intended for medium-term use in retinal surgery

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

We asked attendees and presenters to share their highlights from this year's ESCRS meeting, which included favorites from the official programme and beyond

In the years to come, Ciliatech will release more data around their novel Cilioscleral Interposition Device (CID)

The future of refractive surgery is bright, thanks to OCTs and advances in laser technology

At the meeting, ZEISS Meditec Ophthalmology showcased the VISUMAX 800 and a host of new launches

The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting